A new extract of the plant calendula officinalis produces a dual in vitro effect:: cytotoxic anti-tumor activity and lymphocyte activation

被引:90
作者
Jimenez-Medina, Eva
Garcia-Lora, Angel
Paco, Laura
Algarra, Ignacio
Collado, Antonia
Garrido, Federico
机构
[1] Univ Granada, Hosp Univ Virgen Nieves, Serv Anal Clin & Inmunol, E-18014 Granada, Spain
[2] Univ Jaen, Dept Ciencias Salud, Jaen, Spain
[3] Hosp Univ Virgen Nieves, Unidad Invest, Granada, Spain
关键词
D O I
10.1186/1471-2407-6-119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Phytopharmacological studies of different Calendula extracts have shown antiinflamatory, anti-viral and anti-genotoxic properties of therapeutic interest. In this study, we evaluated the in vitro cytotoxic anti- tumor and immunomodulatory activities and in vivo anti- tumor effect of Laser Activated Calendula Extract ( LACE), a novel extract of the plant Calendula Officinalis ( Asteraceae). Methods: An aqueous extract of Calendula Officinalis was obtained by a novel extraction method in order to measure its anti- tumor and immunomodulatory activities in vitro. Tumor cell lines derived from leukemias, melanomas, fibrosarcomas and cancers of breast, prostate, cervix, lung, pancreas and colorectal were used and tumor cell proliferation in vitro was measured by BrdU incorporation and viable cell count. Effect of LACE on human peripheral blood lymphocyte ( PBL) proliferation in vitro was also analyzed. Studies of cell cycle and apoptosis were performed in LACE-treated cells. In vivo anti- tumor activity was evaluated in nude mice bearing subcutaneously human Ando-2 melanoma cells. Results: The LACE extract showed a potent in vitro inhibition of tumor cell proliferation when tested on a wide variety of human and murine tumor cell lines. The inhibition ranged from 70 to 100%. Mechanisms of inhibition were identified as cell cycle arrest in G0/G1 phase and Caspase-3-induced apoptosis. Interestingly, the same extract showed an opposite effect when tested on PBLs and NKL cell line, in which in vitro induction of proliferation and activation of these cells was observed. The intraperitoneal injection or oral administration of LACE extract in nude mice inhibits in vivo tumor growth of Ando-2 melanoma cells and prolongs the survival day of the mice. Conclusion: These results indicate that LACE aqueous extract has two complementary activities in vitro with potential anti- tumor therapeutic effect: cytotoxic tumor cell activity and lymphocyte activation. The LACE extract presented in vivo anti-tumoral activity in nude mice against tumor growth of Ando-2 melanoma cells.
引用
收藏
页数:14
相关论文
共 32 条
  • [1] Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects
    Akihisa, T
    Yasukawa, K
    Oinuma, H
    Kasahara, Y
    Yamanouchi, S
    Takido, M
    Kumaki, K
    Tamura, T
    [J]. PHYTOCHEMISTRY, 1996, 43 (06) : 1255 - 1260
  • [2] Algarra I, 1999, J EXP CLIN CANC RES, V18, P39
  • [3] BOUCAUDMAITRE Y, 1988, PHARMAZIE, V43, P220
  • [4] Tannins and human health: A review
    Chung, KT
    Wong, TY
    Wei, CI
    Huang, YW
    Lin, Y
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 1998, 38 (06) : 421 - 464
  • [5] A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas
    Crowe, NY
    Smyth, MJ
    Godfrey, DI
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (01) : 119 - 127
  • [6] DELLALOGGIA R, 1994, PLANTA MED, V60, P516, DOI 10.1055/s-2006-959562
  • [7] Demeule Michel, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P441, DOI 10.2174/1568011023353930
  • [8] Role of chemopreventive agents in cancer therapy
    Dorai, T
    Aggarwal, BB
    [J]. CANCER LETTERS, 2004, 215 (02) : 129 - 140
  • [9] Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line
    García-Lora, A
    Pedrinaci, S
    Garrido, F
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (04) : 191 - 198
  • [10] A systematic review of taxane-containing regimens for metastatic breast cancer
    Ghersi, D
    Wilcken, N
    Simes, RJ
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (03) : 293 - 301